Breast cancer patients can be classified into diverse patient subgroups with different prognosis and treatment response according to their classical clinicopathological and molecular features, such as estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2]. The gene discussed is ERBB2; the disease is breast carcinoma.